Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 4 | 312.50 | 180.13 | 300.00 | 215.75 | 1.3905 | 6.0945 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 4 | 312.50 | 180.13 | 386.00 | 215.75 | 1.7891 | 17.6792 |
| SK-BR-3 | PLX-4720 | 10 | uM | 4 | 312.50 | 180.13 | 355.00 | 215.75 | 1.6454 | 12.5428 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 4 | 312.50 | 180.13 | 159.00 | 215.75 | 0.7370 | -0.3807 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 4 | 312.50 | 180.13 | 1320.00 | 215.75 | 6.1182 | 2099.3687 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 4 | 312.50 | 180.13 | 281.00 | 215.75 | 1.3024 | 4.5180 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 4 | 312.50 | 180.13 | 321.00 | 215.75 | 1.4878 | 8.1998 |
| SK-BR-3 | PLX-4720 | 1 | uM | 4 | 312.50 | 180.13 | 254.00 | 215.75 | 1.1773 | 2.7435 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 4 | 312.50 | 180.13 | 241.00 | 215.75 | 1.1170 | 2.0594 |
| SK-BR-3 | Nilotinib | 10 | uM | 4 | 312.50 | 180.13 | 800.00 | 215.75 | 3.7080 | 305.8897 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 4 | 312.50 | 180.13 | 230.00 | 215.75 | 1.0660 | 1.5569 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 4 | 312.50 | 180.13 | 133.00 | 215.75 | 0.6165 | -0.6881 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 185.00 | 215.75 | 0.8575 | 0.1080 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 236.00 | 215.75 | 1.0939 | 1.8227 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 169.00 | 215.75 | 0.7833 | -0.2172 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 251.00 | 215.75 | 1.1634 | 2.5765 | |
| SK-BR-3 | Etoposide | 1 | uM | 4 | 312.50 | 180.13 | 138.00 | 215.75 | 0.6396 | -0.6406 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 4 | 312.50 | 180.13 | 282.00 | 215.75 | 1.3071 | 4.5938 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 332.00 | 215.75 | 1.5388 | 9.4708 | |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 4 | 312.50 | 180.13 | 156.00 | 215.75 | 0.7231 | -0.4244 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 4 | 312.50 | 180.13 | 238.00 | 215.75 | 1.1031 | 1.9157 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 4 | 312.50 | 180.13 | 259.00 | 215.75 | 1.2005 | 3.0345 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 4 | 312.50 | 180.13 | 262.00 | 215.75 | 1.2144 | 3.2170 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 4 | 312.50 | 180.13 | 268.00 | 215.75 | 1.2422 | 3.6002 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 4 | 312.50 | 180.13 | 257.00 | 215.75 | 1.1912 | 2.9162 |